UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 8, 2014
BIOSCRIP, INC.
(Exact name of Registrant as specified in
its charter)
Delaware |
|
000-28740 |
|
05-0489664 |
(State of Incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer |
|
|
|
|
Identification No.) |
100 Clearbrook Road, Elmsford, New York |
|
10523 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (914) 460-1600
N/A
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 5 – Corporate Governance and Management
Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 8, 2014, at the 2014 Annual Meeting
of Stockholders (the “Annual Meeting”) of BioScrip, Inc. (the “Company”), the Company’s stockholders
approved the proposed amendments to the BioScrip, Inc. 2008 Equity Incentive Plan (the “Plan”), as previously described
in the Company’s 2014 definitive proxy materials, to (i) increase by 2,500,000 the number of authorized shares of the Company’s
common stock available for issuance under the Plan, and (ii) clarify that cash dividends or dividend equivalents may not be paid
to holders of unvested restricted stock units, restricted stock grants and performance units until such awards are vested and non-forfeitable.
The Company’s stockholders also re-approved at the Annual Meeting the material terms of the performance goals that are a
part of the Plan, as previously described in the Company’s 2014 definitive proxy materials. The amendments to the Plan and
material terms of the performance goals had been previously approved, subject to stockholder approval, by the Company’s Board
of Directors (the “Board”). The amendments to the Plan became effective immediately upon stockholder approval at the
Annual Meeting. The material terms of the Plan, as amended and restated, are summarized in the Company’s 2014 definitive
proxy materials filed with the Securities and Exchange Commission (collectively, the “Proxy Materials”), and are incorporated
herein by reference. That summary and the foregoing description are qualified in their entirety by reference to the text of the
Plan, as amended and restated, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by
reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
At the Annual Meeting, the stockholders
of the Company (i) elected ten directors to serve for one-year terms, (ii) approved by an advisory non-binding vote the compensation
paid to the Company’s named executive officers, (iii) ratified the appointment of Ernst & Young LLP as the Company’s
independent registered public accounting firm for the fiscal year ending December 31, 2014, and (iv) as described above, approved
amendments to the Plan and re-approved the material terms of the performance goals that are a part of the Plan. The proposals are
described in detail in the Proxy Materials.
On March 19, 2014, the record date for the
Annual Meeting, 68,191,587 shares of the Company’s common stock were issued and outstanding, of which 62,084,009 were present
at the Annual Meeting for purposes of establishing a quorum. The final results for the votes regarding each proposal are set forth
below.
1. Election of ten directors, as set forth in the Proxy Materials,
to each serve a one-year term expiring at the conclusion of the Company’s 2015 Annual Meeting of Stockholders or until their
respective successors are duly elected and qualified:
Name | |
Votes FOR | | |
Votes Withheld | |
Richard M. Smith | |
| 50,299,912 | | |
| 402,804 | |
Charlotte W. Collins | |
| 48,040,817 | | |
| 2,661,899 | |
Samuel P. Frieder | |
| 50,194,850 | | |
| 507,866 | |
Myron Z. Holubiak | |
| 48,394,942 | | |
| 2,307,774 | |
David R. Hubers | |
| 50,198,602 | | |
| 504,114 | |
Yon Y. Jorden | |
| 50,163,494 | | |
| 539,222 | |
Tricia H. Nguyen | |
| 50,244,158 | | |
| 418,558 | |
Richard L. Robbins | |
| 48,262,577 | | |
| 2,440,139 | |
Stuart A. Samuels | |
| 50,197,538 | | |
| 505,178 | |
Gordon H. Woodward | |
| 48,490,166 | | |
| 2,212,550 | |
In addition, there were 11,381,293 broker non-votes for the
election of directors.
2. Approval,
by advisory vote on a non-binding basis, of the compensation paid to the Company’s named executive officers:
Votes FOR | | |
Votes AGAINST | | |
Abstentions | | |
Broker Non-Votes | |
| | | |
| | | |
| | | |
| | |
| 46,538,847 | | |
| 833,868 | | |
| 3,330,001 | | |
| 11,381,293 | |
3. Ratification
of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal
year ending December 31, 2014:
Votes FOR | | |
Votes AGAINST | | |
Abstentions | |
| | | |
| | | |
| | |
| 59,552,661 | | |
| 2,511,139 | | |
| 20,209 | |
4. Approval
of amendments to the Plan to (i) increase by 2,500,000 the number of authorized shares of the Company’s common stock available
for issuance under the Plan, and (ii) clarify that cash dividends or dividend equivalents may not be paid to holders of unvested
restricted stock units, restricted stock grants and performance units until such awards are vested and non-forfeitable, and re-approval
of the material terms of the performance goals that are a part of the Plan:
Votes FOR | | |
Votes AGAINST | | |
Abstentions | | |
Broker Non-Votes | |
| | | |
| | | |
| | | |
| | |
| 36,364,258 | | |
| 14,266,565 | | |
| 71,893 | | |
| 11,381,293 | |
Section 7 – Regulation FD
Item 7.01. Regulation FD Disclosure.
On May 14, 2014, the Company issued a press
release announcing the election at the Annual Meeting of Yon Y. Jorden as a new member of the Board (the “Press Release”).
A copy of the Press Release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
As provided in General Instruction B.2 to
Form 8-K, the information furnished in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that
Section and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly provided by specific reference in such filing.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. See the Exhibit Index which is hereby incorporated
by reference.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
BIOSCRIP, INC. |
|
|
|
Date: May 14, 2014 |
|
By: |
/s/ Kimberlee C. Seah |
|
|
|
Kimberlee C. Seah |
|
|
|
Senior Vice President and General Counsel |
Exhibit
Index
Exhibit No. |
|
Description |
|
|
|
10.1 |
|
Amended and Restated BioScrip, Inc. 2008 Equity Incentive Plan. |
|
|
|
99.1 |
|
Press Release issued by the Company dated May 14, 2014. |
EXHIBIT 10.1
BIOSCRIP, INC.
AMENDED AND RESTATED
2008 EQUITY INCENTIVE PLAN
AS AMENDED
EFFECTIVE AS OF MAY
8, 2014
TABLE OF CONTENTS
Section 1. BACKGROUND AND PURPOSE |
1 |
|
|
Section 2. DEFINITIONS |
1 |
2.2 Award |
1 |
2.3 Award Agreement |
1 |
2.4 Board |
1 |
2.5 Change in Control |
1 |
2.6 Code |
3 |
2.7 Committee |
3 |
2.8 Director |
3 |
2.9 Ending Value |
3 |
2.10 |
Fair Market Value |
3 |
2.11 |
ISO |
3 |
2.12 |
Key Employee |
3 |
2.13 |
1933 Act |
3 |
2.14 |
1934 Act |
3 |
2.15 |
Non-ISO |
3 |
2.16 |
Option |
3 |
2.17 |
Option Certificate |
3 |
2.18 |
Option Price |
3 |
2.19 |
Parent |
3 |
2.20 |
Performance Goal |
3 |
2.21 |
Performance Period |
4 |
2.22 |
Performance Unit |
4 |
2.23 |
Plan |
4 |
2.24 |
Prior Plan |
4 |
2.25 |
Restricted Stock Unit |
4 |
2.26 |
Restricted Stock Unit Certificate |
4 |
2.27 |
Rule 16b-3 |
4 |
2.28 |
SAR Value |
4 |
2.29 |
Stock |
4 |
2.30 |
Stock Appreciation Right |
4 |
2.31 |
Stock Appreciation Right Certificate |
4 |
2.32 |
Stock Grant |
4 |
2.33 |
Stock Grant Certificate |
4 |
2.34 |
Subsidiary |
4 |
2.35 |
Substitute Awards |
4 |
2.36 |
Ten Percent Shareholder |
4 |
|
|
|
Section 3. SHARES RESERVED UNDER PLAN |
5 |
3.1 Number of Shares |
5 |
3.2 Character of Shares |
6 |
|
|
Section 4. EFFECTIVE DATE |
6 |
Section 5. COMMITTEE |
6 |
5.1 Committee Powers |
6 |
5.2 Committee Decisions and Meetings |
7 |
5.3 Delegation |
7 |
|
|
Section 6. ELIGIBILITY AND ANNUAL GRANT CAPS |
7 |
|
|
Section 7. OPTIONS |
7 |
7.1 Committee Action |
7 |
7.2 $100,000 Limit |
8 |
7.3 Option Price |
8 |
7.4 Payment |
8 |
7.5 Exercise Period |
8 |
7.6 Reload Option Grants Prohibited |
9 |
|
|
Section 8. STOCK APPRECIATION RIGHTS |
9 |
8.1 Committee Action |
9 |
8.2 Terms and Conditions |
9 |
8.3 Exercise |
10 |
|
|
Section 9. RESTRICTED STOCK UNITS |
10 |
9.1 Committee Action |
10 |
9.2 No Adjustment for Cash Dividends |
10 |
9.3 Payment for Restricted Stock Units |
10 |
9.4 Deferrals |
11 |
9.5 Performance-Based Vesting |
11 |
|
|
Section 10. STOCK GRANTS |
11 |
10.1 |
Committee Action |
11 |
10.2 |
Conditions |
11 |
10.3 |
Dividends and Voting Rights |
12 |
10.4 |
Satisfaction of Forfeiture Conditions |
12 |
10.5 |
Performance-Based Vesting |
12 |
|
|
|
Section 11. PERFORMANCE UNITS |
13 |
11.1 |
Committee Action |
13 |
11.2 |
Conditions |
13 |
11.3 |
Performance Goals |
13 |
11.4 |
Performance Period |
14 |
11.5 |
Payment for Performance Units |
14 |
|
|
|
Section 12. NON-TRANSFERABILITY |
14 |
|
|
Section 13. SECURITIES REGISTRATION |
14 |
|
|
Section 14. LIFE OF PLAN |
15 |
Section 15. ADJUSTMENT |
15 |
15.1 |
Capital Structure |
15 |
15.2 |
Mergers |
15 |
15.3 |
Fractional Shares |
16 |
|
|
|
Section 16. CHANGE IN CONTROL |
16 |
16.1 |
Assumption or Substitution of Certain Awards |
16 |
16.2 |
Non-Assumption or Substitution of Certain Awards |
17 |
16.3 |
Impact on Certain Awards |
17 |
16.4 |
Termination of Certain Awards |
17 |
|
|
|
Section 17. AMENDMENT OR TERMINATION |
17 |
|
|
Section 18. MISCELLANEOUS |
18 |
18.1 |
Stockholder Rights |
18 |
18.2 |
No Contract of Employment or Service |
18 |
18.3 |
Withholding |
18 |
18.4 |
Construction |
18 |
18.5 |
Other Conditions |
18 |
18.6 |
Rule 16b-3 |
18 |
Section
1.
BACKGROUND
AND PURPOSE
The purpose of this
Plan is to promote the interest of BioScrip, Inc. (the “Company”), a Delaware corporation, by authorizing the Committee
to grant Awards to Key Employees and Directors in order (1) to attract and retain Key Employees and Directors, (2) to provide an
additional incentive to each Key Employee and Director to work to increase the value of Stock and (3) to provide each Key Employee
and Director with a stake in the future of the Company which corresponds to the stake of each of the Company’s stockholders.
Section
2.
DEFINITIONS
2.1 Affiliate
— means any organization (other than a Subsidiary) that would be treated as under common control with the Company under §
414(c) of the Code if “50 percent” were substituted for “80 percent” in the income tax regulations under
§ 414(c) of the Code.
2.2 Award
— means any Option, Stock Appreciation Right, Restricted Stock Unit, Stock Grant or Performance Unit made pursuant to the
provisions of the Plan.
2.3 Award
Agreement — means any Option Certificate, Restricted Stock Unit Certificate, Stock Appreciation Right Certificate, or
Stock Grant Certificate.
2.4 Board
— means the Board of Directors of the Company.
2.5 Change
in Control — means unless otherwise provided in an Award Agreement, the occurrence of any one of the following events:
(a) During
any twenty-four (24) month period, individuals who, as of the beginning of such period, constitute the Board (the “Incumbent
Directors”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director
subsequent to the beginning of such period whose election or nomination for election was approved by a vote of at least a majority
of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in
which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director;
provided, however, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened
election contest with respect to directors or as a result of any other actual or threatened solicitation of proxies by or on behalf
of any person other than the Board shall be deemed to be an Incumbent Director;
(b) Any
“person” or “group” (within the meaning of Sections 13(d) and 14(d) of the Securities Exchange Act of 1934
(the “Exchange Act”)) is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, of securities of the Company representing 30% or more of the combined voting power of the Company’s
then outstanding securities eligible to vote for the election of the Board (the “Company Voting Securities”); provided,
however, that the event described in this paragraph (b) shall not be deemed to be a Change in Control by virtue of any of the following
acquisitions: (i) by the Company or any Affiliate or Subsidiary, (ii) by any employee benefit plan (or related trust) sponsored
or maintained by the Company or any Affiliate or Subsidiary, (iii) by any underwriter temporarily holding securities pursuant to
an offering of such securities, (iv) pursuant to a Non-Qualifying Transaction, as defined in paragraph (c), or (v) by any person
of or group of Voting Securities from the Company, if a majority of the Incumbent Board approves in advance the acquisition of
beneficial ownership of 30% or more of Company Voting Securities by such person or group;
(c) The
consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company
or any of its subsidiaries that requires the approval of the Company’s stockholders, whether for such transaction or the
issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business Combination:
(i) more than 50% of the total voting power of (A) the corporation resulting from such Business Combination (the “Surviving
Corporation”), or (B) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership
of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”),
is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable,
is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such
voting power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities
among the holders thereof immediately prior to the Business Combination, (ii) no person (other than any employee benefit plan (or
related trust) sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial owner,
directly or indirectly, of 30% or more of the total voting power of the outstanding voting securities eligible to elect directors
of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (iii) at least a majority of the
members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation)
following the consummation of the Business Combination were Incumbent Directors at the time of the Board’s approval of the
execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the
criteria specified in (i), (ii) and (iii) above shall be deemed to be a “Non-Qualifying Transaction”);
(d) The
stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or the consummation of a sale
of all or substantially all of the Company’s assets; or
Notwithstanding the
foregoing, a Change in Control shall not be deemed to occur solely because any person acquires beneficial ownership of more than
30% of the Company Voting Securities as a result of the acquisition of Company Voting Securities by the Company which reduces the
number of Company Voting Securities outstanding; provided, that if after such acquisition by the Company such person becomes the
beneficial owner of additional Company Voting Securities that increases the percentage of outstanding Company Voting Securities
beneficially owned by such person, a Change in Control of the Company shall then occur.
2.6 Code
— means the Internal Revenue Code of 1986, as amended.
2.7 Committee — means the Management Development & Compensation Committee, or such other committee appointed by the Board,
which shall have at least 2 members, each of whom shall come within the definition of a “non-employee director” under
Rule 16b-3 and an “outside director” under § 162(m) of the Code.
2.8 Director — means a non-employee member of the Board.
2.9 Ending
Value — means, a value for each Performance Unit or a formula for determining the value of each Performance Unit
at the time of payment.
2.10 Fair
Market Value — means (1) the closing price on any date for a share of Stock on the principal securities exchange
on which the Stock is traded or listed or, if no such closing price is available on such date, (2) such closing price as so reported
in accordance with clause (1) for the immediately preceding business day, or, if the Stock is not traded or listed on any securities
exchange, (3) the price which the Committee acting in good faith determines through any reasonable valuation method that a share
of Stock might change hands between a willing buyer and a willing seller, neither being under any compulsion to buy or to sell
and both having reasonable knowledge of the relevant facts.
2.11 ISO
— means an Option which is intended to satisfy the requirements of § 422 of the Code.
2.12 Key
Employee — means an employee of the Company or any Subsidiary or Parent or Affiliate designated by the Committee
who, in the judgment of the Committee acting in its absolute discretion, is key directly or indirectly to the success of the Company.
2.13 1933
Act — means the Securities Act of 1933, as amended.
2.14 1934
Act — means the Securities Exchange Act of 1934, as amended.
2.15 Non-ISO — means an Option which is not intended to satisfy the requirements of § 422 of the Code.
2.16 Option
— means an option to purchase Stock which is granted under § 7.
2.17 Option
Certificate — means the written certificate which sets forth the terms and conditions of an Option granted under
this Plan.
2.18 Option
Price — means the price which shall be paid to purchase one share of Stock upon the exercise of an Option granted
under this Plan.
2.19 Parent
— means any corporation which is a parent corporation (within the meaning of § 424(e) of the Code) of the Company.
2.20 Performance
Goal — means a performance goal described in § 11.3.
2.21 Performance
Period — means a performance period as described in § 11.4.
2.22 Performance
Unit — means an Award granted under § 11.
2.23 Plan
— means this BioScrip, Inc. 2008 Equity Incentive Plan as adopted by the Board and as amended from time to time thereafter.
2.24 Prior
Plan — means the Company’s 2001 Incentive Stock Plan.
2.25 Restricted
Stock Unit — means an Award granted under Section 9.
2.26 Restricted
Stock Unit Certificate — means the written certificate which sets forth the terms and conditions of a Restricted Stock
Unit.
2.27 Rule
16b-3 — means the exemption under Rule 16b-3 to Section 16(b) of the 1934 Act or any successor to such rule.
2.28 SAR
Value — means the value assigned by the Committee to a share of Stock in connection with the grant of a Stock Appreciation
Right under § 8.
2.29 Stock
— means the common stock, $.0001 par value per share, of the Company.
2.30 Stock
Appreciation Right — means a right to receive the appreciation in a share of Stock which is granted under § 8.
2.31 Stock
Appreciation Right Certificate — means the written certificate which sets forth the terms and conditions of a Stock
Appreciation Right which is not granted to a Key Employee as part of an Option.
2.32 Stock
Grant — means Stock granted under § 10.
2.33 Stock
Grant Certificate — means the written certificate which sets forth the terms and conditions of a Stock Grant.
2.34 Subsidiary — means a corporation which is a subsidiary corporation (within the meaning of § 424(f) of the Code) of the
Company.
2.35 Substitute
Awards — Awards granted or shares of Stock issued by the Company in assumption of, or in substitution or exchange for,
awards previously granted, or the right or obligation to make future awards, in each case by a company acquired by the Company
or any Affiliate or Subsidiary or with which the Company or any Affiliate or Subsidiary combines.
2.36 Ten
Percent Shareholder — means a person who owns (after taking into account the attribution rules of § 424(d) of the
Code) more than ten percent of the total combined voting power of all classes of stock of either the Company, a Subsidiary or
Parent.
Section
3.
SHARES
RESERVED UNDER PLAN
3.1 Number
of Shares
(a) Subject
to adjustment as provided in Section 15, a total of 9,355,000 shares of Stock shall be authorized for issuance under the Plan (which
number shall include the 6,855,000 shares of Stock previously authorized for issuance under the Plan), all of which may be subject
to ISOs, less one (1) share of Stock for every one (1) share of Stock that was subject to an Option or Stock Appreciation Right
granted after December 31, 2007 under the Prior Plan and one and 53/100 (1.53) shares of Stock for every one (1) share of Stock
that was subject to an Award other than an Option or Stock Appreciation Right granted after December 31, 2007 under the Prior Plan.
In no event may more than 800,000 shares of Stock in the aggregate be subject to Awards granted to Directors. Any shares of Stock
that are subject to Awards of Options or Stock Appreciation Rights shall be counted against this limit as one (1) share of Stock
for every one (1) share of Stock issued. Any shares of Stock that are subject to Awards other than Options or Stock Appreciation
Rights shall be counted against this limit as one and 53/100 (1.53) shares of Stock for every one (1) share of Stock issued.
(b) If
any shares of Stock subject to an Award, or after December 31, 2007 an award under the Prior Plan, are forfeited or expire, or
any Award, or after December 31, 2007 an award under the Prior Plan, is settled for cash (in whole or in part), the shares of Stock
subject to such Award or such award under the Prior Plan shall, to the extent of such forfeiture, expiration or cash settlement,
again be available for Awards under the Plan, in accordance with Section 3.1(d) below. Notwithstanding anything to the contrary
contained herein, the following shares of Stock shall not be added to the shares of Stock authorized for issuance under paragraph
(a) of this Section: (i) shares of Stock tendered by the Key Employee or Director or withheld by the Company in payment of the
purchase price of an Option, (ii) shares of Stock tendered by the Key Employee or withheld by the Company to satisfy any tax withholding
obligation with respect to an Award, and (iii) shares of Stock subject to a Stock Appreciation Right that are not issued in connection
with the stock settlement of the Stock Appreciation Right on exercise thereof.
(c) Substitute
Awards shall not reduce the shares of Stock authorized for issuance under the Plan or authorized for grant to a Participant under
Section 6. Additionally, in the event that a company acquired by the Company or any Affiliate or Subsidiary or with which the Company
or any Affiliate or Subsidiary combines has shares available under a pre-existing plan approved by stockholders and not adopted
in contemplation of such acquisition or combination, the shares available for issuance pursuant to the terms of such pre-existing
plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in
such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to
such acquisition or combination) may be used for Awards under the Plan and shall not reduce the shares of Stock authorized for
issuance under the Plan; provided that Awards using such available shares shall not be made after the date awards or grants could
have been made under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals
who were not employees or directors of the Company, an Affiliate or a Subsidiary prior to such acquisition or combination.
(d) Any
shares of Stock that again become available for issuance pursuant to this Article shall be added back as one (1) share of Stock
if such shares of Stock were subject to Options or Stock Appreciation Rights granted under the Plan or options or stock appreciation
rights granted under the Prior Plan, and as one and 53/100 (1.53) shares of Stock if such shares of Stock were subject to Awards
other than Options or Stock Appreciation Rights granted under the Plan or awards other than options or stock appreciation rights
granted under the Prior Plan.
3.2 Character
of Shares. Any Shares issued hereunder may consist, in whole or in part, of authorized and unissued shares, treasury shares
or shares purchased in the open market or otherwise.
Section
4.
EFFECTIVE
DATE
The effective date
of this Plan shall be the date of its approval by the shareholders of the Company at a duly called meeting.
Section
5.
COMMITTEE
5.1 Committee
Powers. This Plan shall be administered by the Committee. The Committee shall have full power and authority, subject to the
provisions of the Plan and subject to such orders or resolutions not inconsistent with the provisions of the Plan as may from time
to time be adopted by the Board, to: (i) select the Key Employees and Directors to whom Awards may from time to time be granted
hereunder; (ii) determine the type or types of Awards, not inconsistent with the provisions of the Plan, to be granted to each
Participant hereunder; (iii) determine the number of shares of Stock to be covered by each Award granted hereunder; (iv) determine
the terms and conditions, not inconsistent with the provisions of the Plan, of any Award granted hereunder; (v) determine whether,
to what extent and under what circumstances Awards may be settled in cash, shares of Stock or other property; (vi) determine whether,
to what extent, and under what circumstances cash, shares of Stock, other property and other amounts payable with respect to an
Award made under the Plan shall be deferred either automatically or at the election of the Key Employee or Director; (vii) determine
whether, to what extent and under what circumstances any Award shall be canceled or suspended; (viii) interpret and administer
the Plan and any instrument or agreement entered into under or in connection with the Plan, including any Award Agreement; (ix)
correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent
that the Committee shall deem desirable to carry it into effect; (x) establish such rules and regulations and appoint such agents
as it shall deem appropriate for the proper administration of the Plan; (xi) determine whether any Award, other than an Option
or Stock Appreciation Right, will have dividend equivalents; and (xii) make any other determination and take any other action that
the Committee deems necessary or desirable for administration of the Plan.
5.2 Committee
Decisions and Meetings. Decisions of the Committee shall be final, conclusive and binding on all persons or entities, including
the Company, any Affiliate or Subsidiary, and any Participant employed by any of the foregoing. A majority of the members of the
Committee may determine its actions, including fixing the time and place of its meetings. Notwithstanding the foregoing, any action
or determination by the Committee specifically affecting or relating to an Award to a Director shall require the prior approval
of the Board.
5.3 Delegation.
To the extent not inconsistent with applicable law, including Section 162(m) of the Code, or the rules and regulations of the principal
securities exchange on which the Stock is traded or listed, the Committee may delegate, by means of an express resolution that
sets forth the requirements and limitations relating to the delegation and the procedures to be followed to grant any Awards, to
(i) a committee of one or more directors of the Company any of the authority of the Committee under the Plan, including the right
to grant, cancel or suspend Awards and (ii) to the extent permitted by law, to one or more executive officers or a committee of
executive officers the right to grant Awards to Key Employees who are not Directors or executive officers of the Company and the
authority to take action on behalf of the Committee pursuant to the Plan to cancel or suspend Awards to Key Employees who are not
Directors or executive officers of the Company.
Section
6.
ELIGIBILITY
AND ANNUAL GRANT CAPS
Only Key Employees
who are employed by the Company or a Subsidiary or Parent shall be eligible for the grant of ISOs under this Plan. No Key Employee
in any calendar year shall be granted (subject to adjustment under § 15) (i) Options to purchase more than 500,000 shares
of Stock, (ii) more than 500,000 Stock Appreciation Rights based on the appreciation with respect to shares of Stock, and (iii)
Stock Grants and Restricted Stock Units that are intended to comply with the requirements of Section 162(m) of the Code representing
more than 350,000 shares of Stock.
Section
7.
OPTIONS
7.1 Committee
Action. The Committee acting in its absolute discretion shall have the right to grant Options to Key Employees and Directors
under this Plan from time to time to purchase shares of Stock. Each grant of an Option shall be evidenced by an Option Certificate,
and each Option Certificate shall set forth whether the Option is an ISO or a Non-ISO and shall set forth such other terms and
conditions of such grant as the Committee acting in its absolute discretion deems consistent with the terms of this Plan; however,
if the Committee grants an ISO and a Non-ISO to a Key Employee on the same date, the right of the Key Employee to exercise the
ISO shall not be conditioned on his or her failure to exercise the Non-ISO.
7.2 $100,000
Limit. No Option shall be treated as an ISO to the extent that the aggregate Fair Market Value of the Stock subject to the
Option which would first become exercisable in any calendar year exceeds $100,000. Any such excess shall instead automatically
be treated as a Non-ISO. The Committee shall interpret and administer the ISO limitation set forth in this § 7.2 in accordance
with § 422(d) of the Code, and the Committee shall treat this § 7.2 as in effect only for those periods for which §
422(d) of the Code is in effect.
7.3 Option
Price. The Option Price for each share of Stock subject to an Option (other than with respect to a Substitute Award) shall
be no less than the Fair Market Value of a share of Stock on the date the Option is granted; provided, however, if the Option is
an ISO granted to a Key Employee who is a Ten Percent Shareholder, the Option Price for each share of Stock subject to such ISO
shall be no less than 110% of the Fair Market Value of a share of Stock on the date such ISO is granted. Except for adjustments
under § 15, without the approval of the Company’s stockholders the Option Price shall not be reduced after the Option
is granted, an Option may not be cancelled in exchange for cash or another Award (other than in connection with a Change in Control
or a Substitute Award), and no other action may be with respect to an Option that would be treated as a repricing under the rules
and regulations of the principal securities exchange on which the Stock is traded.
7.4 Payment.
The Option Price shall be payable in full upon the exercise of any Option, and at the discretion of the Committee an Option Certificate
can provide for the payment of the Option Price either in cash, by check or in Stock and which is acceptable to the Committee or
in any combination of cash, check and such Stock. The Option Price in addition may be paid (i) through any cashless exercise procedure
which is acceptable to the Committee or its delegate and which is facilitated through a sale of Stock, (ii) with the consent of
the Committee, by withholding Stock otherwise issuable in connection with the exercise of the Option, and (iii) through any other
method specified in an Award agreement. Any payment made in Stock (including withholding of Stock) shall be treated as equal to
the Fair Market Value of such Stock on the exercise date.
7.5 Exercise
Period. Each Option granted under this Plan shall be exercisable in whole or in part at such time or times as set forth in
the related Option Certificate, but in no event may an Option granted to an employees of the Company or any Subsidiary be exercisable
before the expiration of one year from the date the Option is granted (but may become exercisable pro rata over such time), except
for Substitute Awards, under circumstances contemplated by Article 16, as may be set forth in an Award Agreement with respect to
the retirement, death or disability of a Participant or special circumstances determined by the Committee. No Option Certificate
shall make an Option exercisable on or after the earlier of (1) the date which is the fifth anniversary of the date the Option
is granted, if the Option is an ISO and the Key Employee is a Ten Percent Shareholder on the date the Option is granted, or (2)
the date which is the tenth anniversary of the date the Option is granted, if the Option is (a) a Non-ISO or (b) an ISO which is
granted to a Key Employee who is not a Ten Percent Shareholder on the date the Option is granted.
An Option Certificate
may provide for the exercise of an Option after the employment of a Key Employee or service of a Director has terminated for any
reason whatsoever, including death or disability.
7.6 Reload
Option Grants Prohibited. The Committee may not, as part of the grant of an Option, provide in the related Option Certificate
for “reload” Option grants (i.e., the automatic grant of an additional Option to pay all or a part of the Option Price
or using Stock to satisfy all or a part of any related tax withholding requirement).
Section
8.
STOCK
APPRECIATION RIGHTS
8.1 Committee
Action. The Committee acting in its absolute discretion shall have the right to grant Stock Appreciation Rights to Key Employees
and Directors under this Plan from time to time, and each Stock Appreciation Right grant shall be evidenced by a Stock Appreciation
Right Certificate or, if such Stock Appreciation Right is granted as part of an Option, shall be evidenced by the Option Certificate
for the related Option.
8.2 Terms
and Conditions.
(a) Stock
Appreciation Right Certificate. If a Stock Appreciation Right is evidenced by a Stock Appreciation Right Certificate, such
certificate shall set forth the number of shares of Stock on which the Key Employee’s or Director’s right to appreciation
shall be based and the SAR Value of each share of Stock. Such SAR Value shall be no less than the Fair Market Value of a share
of Stock on the date that the Stock Appreciation Right is granted. Except for adjustments under § 15, without the approval
of the Company’s stockholders the SAR Value shall not be reduced after the Stock Appreciation Right is granted, a Stock Appreciation
Right may not be cancelled in exchange for cash or another Award (other than in connection with a Change in Control or a Substitute
Award), and no other action may be taken with respect to a Stock Appreciation Right that would be treated as a repricing under
the rules and regulations of the principal securities exchange on which the Stock is traded. The Stock Appreciation Right Certificate
shall set forth such other terms and conditions for the exercise of the Stock Appreciation Right as the Committee deems appropriate
under the circumstances, but in no event may a Stock Appreciation Right granted to an employee of the Company or any Subsidiary
be exercisable before the expiration of one year from the date the Stock Appreciation Right is granted (but may become exercisable
pro rata over such time), except for Substitute Awards, under circumstances contemplated by Article 16 or as may be set forth in
an Award Agreement with respect to the retirement, death or disability of the Key Employee or Director or (ii) special circumstances
determined by the Committee (such as the achievement of performance objectives). No Stock Appreciation Right Certificate shall
make a Stock Appreciation Right exercisable on or after the date which is the tenth anniversary of the date such Stock Appreciation
Right is granted.
(b) Option
Certificate. If a Stock Appreciation Right is evidenced by an Option Certificate, the number of shares of Stock on which the
Key Employee’s or Director’s right to appreciation shall be based shall be the same as the number of shares of Stock
subject to the related Option and the SAR Value for each such share of Stock shall be no less than the Option Price under the related
Option. Each such Option Certificate shall provide that the exercise of the Stock Appreciation Right with respect to any share
of Stock shall cancel the Key Employee’s or Director’s right to exercise his or her Option with respect to such share
and, conversely, that the exercise of the Option with respect to any share of Stock shall cancel the Key Employee’s or Director’s
right to exercise his or her Stock Appreciation Right with respect to such share. A Stock Appreciation Right which is granted as
part of an Option shall be exercisable only while the related Option is exercisable. The Option Certificate shall set forth such
other terms and conditions for the exercise of the Stock Appreciation Right as the Committee deems appropriate under the circumstances.
8.3 Exercise.
A Stock Appreciation Right shall be exercisable only when the Fair Market Value of a share of Stock on which the right to appreciation
is based exceeds the SAR Value for such share, and the payment due on exercise shall be based on such excess with respect to the
number of shares of Stock to which the exercise relates. A Key Employee or Director upon the exercise of his or her Stock Appreciation
Right shall receive a payment from the Company in cash or in Stock issued under this Plan, or in a combination of cash and Stock,
and the number of shares of Stock issued shall be based on the Fair Market Value of a share of Stock on the date the Stock Appreciation
Right is exercised. The Committee acting in its absolute discretion shall have the right to determine the form and time of any
payment under this § 8.3.
Section
9.
RESTRICTED
STOCK UNITS
9.1 Committee
Action. The Committee acting in its absolute discretion shall have the right from time to time to grant to Key Employees and
Directors under this Plan Restricted Stock Units, the value of each of which corresponds to the Fair Market Value of a share of
Stock. Each Restricted Stock Unit grant shall be evidenced by a Restricted Stock Unit Certificate that shall set forth the number
of Restricted Stock Units granted to the Key Employee or Director, the vesting schedule applicable to such Restricted Stock Units
and such other terms and conditions of such grant as the Committee acting in its absolute discretion deems consistent with the
terms of this Plan. Restricted Stock Units subject solely to continued service with the Company or a Subsidiary shall not become
vested over a period of less than (i) three (3) years from the date of grant (but permitting pro rata vesting over such period)
for grants to Key Employees and (ii) one (1) year from the date of grant (but permitting pro rata vesting over such period) for
grants to Directors; provided that such restrictions shall not be applicable to grants not in excess of 10% of the initial number
of shares available for grants of Restricted Stock Units under Section 3.1(a). Restricted Stock Unit subject to the achievement
of performance objectives shall not become vested over a period of less than one (1) year.
9.2 No
Adjustment for Cash Dividends. Except for dividend equivalent adjustments made by the Committee for stock dividends in accordance
with § 15.1, there shall be no adjustment to Restricted Stock Units for dividends paid by the Company.
9.3 Payment
for Restricted Stock Units. Unless a Key Employee or Director has made a deferral election in accordance with § 9.4, a
Key Employee or Director shall receive upon the vesting of a Restricted Stock Unit payment from the Company in Stock issued under
this Plan, and the number of shares of Stock issued to the Key Employee or Director shall be equal to the number of Restricted
Stock Units that have at such time become vested. At the time a Key Employee or Director receives shares of stock equal in number
to such Key Employee’s or Director’s vested Restricted Stock Units, such vested Restricted Stock Units shall automatically
be cancelled and shall give the Key Employee or Director no further rights to payment of any kind.
9.4 Deferrals.
The Committee, in its absolute discretion, may permit a Key Employee or Director to elect to defer such Key Employee’s or
Director’s receipt of the delivery of shares of Stock that would otherwise be due to such Key Employee or Director by virtue
of the vesting of a Restricted Stock Unit; provided such deferral election is made in accordance with the requirements of Section
409A of the Code. If any such deferral election is permitted by the Committee, the Committee shall, in its absolute discretion,
establish additional rules and procedures for such payment deferrals. However, notwithstanding the preceding provisions of this
Section and notwithstanding any other provision of this Plan to the contrary, the Committee shall not, (1) in establishing the
terms and provisions of any grant of Restricted Stock Units, or (2) in exercising its powers under this § 9.4, create any
arrangement which would constitute an employee pension benefit plan as defined in § 3(2) of the Employee Retirement Income
Security Act of 1974, as amended (“ERISA”), unless the arrangement provides benefits solely to one or more individuals
who constitute members of a select group of management or highly compensated employees (within the meaning of ERISA §§
201(2), 301(a)(3), 401(a)(1) and 4021(b)(6)).
9.5 Performance-Based
Vesting. Notwithstanding anything contained in Section 9.1 hereof, the Committee may, at the time of grant of Restricted Stock
Units to Key Employees, prescribe that vesting of all or any the Restricted Stock Units shall be subject to the achievement of
one or more performance objectives, including the Performance Goals set forth in § 11.3.
Section
10.
STOCK
GRANTS
10.1 Committee
Action. The Committee acting in its absolute discretion shall have the right to make Stock Grants to Key Employees and Directors.
Each Stock Grant shall be evidenced by a Stock Grant Certificate, and each Stock Grant Certificate shall set forth the conditions,
if any, under which Stock will be issued under the Stock Grant and the conditions under which the Key Employee’s or Director’s
interest in any Stock which has been issued will become non-forfeitable.
10.2 Conditions.
(a) Conditions
to Issuance of Stock. The Committee acting in its absolute discretion may make the issuance of Stock under a Stock Grant subject
to the satisfaction of one, or more than one, condition which the Committee deems appropriate under the circumstances for Key Employees
or Directors generally or for a Key Employee or Director in particular, and the related Stock Grant Certificate shall set forth
each such condition and the deadline for satisfying each such condition. Stock subject to a Stock Grant shall be issued in the
name of a Key Employee or Director only after each such condition, if any, has been timely satisfied, and any Stock which is so
issued shall be held by the Company pending the satisfaction of the forfeiture conditions, if any, under § 10.2(b) for the
related Stock Grant.
(b) Forfeiture
Conditions. The Committee acting in its absolute discretion may make Stock issued in the name of a Key Employee or Director
subject to one, or more than one, objective employment, performance or other forfeiture condition that the Committee acting in
its absolute discretion deems appropriate under the circumstances for Key Employees or Directors generally or for a Key Employee
or Director in particular, and the related Stock Grant Certificate shall set forth each such forfeiture condition, if any, and
the deadline, if any, for satisfying each such forfeiture condition. A Stock Grant Certificate may not provide for vesting of the
Stock Grant subject solely to continued service with the Company or a Subsidiary over a period of less than three (3) years from
the date of grant (which may be pro rata over such period) for grants to Key Employees and (ii) one (1) year from the date of grant
(but permitting pro rata vesting over such period) for grants to Directors; provided that such restrictions shall not be applicable
to Stock Grants not in excess of 10% of the initial number of shares available for Stock Grants under Section 3. Stock Grants subject
to the achievement of performance conditions shall not become vested over a period of less than one (1) year. A Key Employee’s
or Director’s non-forfeitable interest in the shares of Stock underlying a Stock Grant shall depend on the extent to which
he or she timely satisfies each such condition.
10.3 Dividends
and Voting Rights. If a cash dividend is paid on a share of Stock after such Stock has been issued under a Stock Grant but
before the first date that a Key Employee’s or Director’s interest in such Stock (1) is forfeited completely or (2)
becomes completely non-forfeitable, the Company shall pay such cash dividend directly to such Key Employee or Director except as
otherwise be provided in the Award agreement. If a Stock dividend is paid on such a share of Stock during such period, such Stock
dividend shall be treated as part of the related Stock Grant, and a Key Employee’s or Director’s interest in such Stock
dividend shall be forfeited or shall become non-forfeitable at the same time as the Stock with respect to which the Stock dividend
was paid is forfeited or becomes non-forfeitable. In no event shall any cash dividends or dividend equivalents be paid with respect
to an Award of Restricted Stock Unit, Stock Grant or Performance Unit until such Award is vested and non-forfeitable, it being
understood that dividends or dividend equivalents may be credited with respect to such Award, with payment subject to such Award
actually vesting (if any). The disposition of each other form of dividend which is declared on such a share of Stock during such
period shall be made in accordance with such rules as the Committee shall adopt with respect to each such dividend. A Key Employee
or Director also shall have the right to vote the Stock issued under his or her Stock Grant during such period.
10.4 Satisfaction
of Forfeiture Conditions. A share of Stock shall cease to be subject to a Stock Grant at such time as a Key Employee’s
or Director’s interest in such Stock becomes non-forfeitable under this Plan, and the certificate representing such share
shall be transferred to the Key Employee or Director as soon as practicable thereafter.
10.5 Performance-Based
Vesting. The Committee may, at the time a Stock Grant is made, prescribe that vesting of all or any portion of the shares subject
to the Stock Grant shall be subject to the achievement of one or more performance conditions, including the Performance Goals set
forth in § 11.3.
Section
11.
PERFORMANCE
UNITS
11.1 Committee
Action. The Committee (acting in its sole discretion) may from time to time grant Performance Units to Key Employees under
the Plan representing the right to receive in cash an amount determined by reference to certain performance measurements, subject
to such restrictions, conditions and other terms as the Committee may determine.
11.2 Conditions.
The written agreement covering Performance Units shall specify Performance Goals (as defined in § 11.3), a Performance Period
(as defined in § 11.4)) and an Ending Value. Performance Units granted to a Key Employee shall be credited to a bookkeeping
account established and maintained for such Key Employee.
11.3 Performance
Goals. With respect to each award of Performance Units, the Committee (acting in its sole discretion) shall specify as Performance
Goals the corporate, division, segment, business unit, and/or individual performance goals which must be satisfied in order for
the Key Employee to be entitled to payment to such Performance Units. Performance Goals for an Award of Performance Units that
is intended to satisfy the requirements of Section 162(m) of the Code shall be based on achieving specified levels of one or any
combination of the following with respect to the Company on a consolidated basis, by division, segment, and/or business unit: net
sales; revenue; revenue growth or product revenue growth; operating income (before or after taxes); pre- or after-tax income (before
or after allocation of corporate overhead and bonus); earnings per share; net income (before or after taxes); return on equity;
total stockholder return; return on assets or net assets; appreciation in and/or maintenance of the price of the Shares or any
other publicly-traded securities of the Company; market share; gross profits; earnings (including earnings before taxes, earnings
before interest and taxes, earnings before interest, taxes, depreciation and amortization or earnings before interest, taxes, depreciation,
amortization and option expense); economic value-added models or equivalent metrics; comparisons with various stock market indices;
reductions in costs; cash flow or cash flow per share (before or after dividends); return on capital (including return on total
capital or return on invested capital); cash flow return on investment; improvement in or attainment of expense levels or working
capital levels; operating margins, gross margins or cash margin; year-end cash; debt reductions; stockholder equity; specific and
objectively determinable regulatory achievements; and implementation, completion or attainment of specific and objectively determinable
objectives with respect to research, development, products or projects, production volume levels, acquisitions and divestitures
and recruiting and maintaining personnel. The Performance Goals also may be based solely by reference to the Company’s performance
or the performance of a Subsidiary, division, business segment or business unit of the Company, or based upon the relative performance
of other companies or upon comparisons of any of the indicators of performance relative to other companies. The Committee may express
any goal in alternatives, such as including or excluding (a) any acquisitions or dispositions, restructurings, discontinued operations,
extraordinary items, and other unusual or non-recurring charges, (b) any event either not directly related to the operations of
the Company or not within the reasonable control of the Company’s management, or (c) the cumulative effects of tax or accounting
changes in accordance with U.S. generally accepted accounting principles.
11.4 Performance
Period. The Committee (acting in its sole discretion) shall determine the Performance Period, which shall be the period of
time during which the Performance Goals must be satisfied in order for the Key Employee to be entitled to payment of Performance
Units granted to such Key Employee. Different Performance Periods may be established for different Performance Units. Performance
Periods may run consecutively or concurrently.
11.5 Payment
for Performance Units. As soon as practicable following the end of a Performance Period, the Committee shall determine whether
the Performance Goals for the Performance Period have been achieved. As soon as reasonably practicable after such determination,
or at such later date or in such installments as the Committee shall determine at the time of grant, the Company shall pay to the
Key Employee an amount in cash equal to the Ending Value of each Performance Unit as to which the Performance Goals have been satisfied;
provided, however, that in no event shall a Key Employee receive an amount in excess of $1,000,000 in respect of Performance Units
for any given year.
Section
12.
NON-TRANSFERABILITY
Except as provided
below, no Award shall be transferable by a Key Employee or Director other than by will or by the laws of descent and distribution.
Any Option or Stock Appreciation Right shall (absent the Committee’s consent) be exercisable during a Key Employee’s
or Director’s lifetime only by the Key Employee or Director. To the extent and under such terms and conditions as determined
by the Committee, a Key Employee or Director may assign or transfer an Award (each transferee thereof, a “Permitted Assignee”)
to (i) the Key Employee’s or Director’s spouse, children or grandchildren (including any adopted and step children
or grandchildren), parents, grandparents or siblings, (ii) to a trust for the benefit of one or more of the Key Employee or Director
or the persons referred to in clause (i), (iii) to a partnership, limited liability company or corporation in which the Key Employee
or Director or the persons referred to in clause (i) are the only partners, members or stockholders or (iv) for charitable donations;
provided that such Permitted Assignee shall be bound by and subject to all of the terms and conditions of the Plan and the Award
Agreement relating to the transferred Award and shall execute an agreement satisfactory to the Company evidencing such obligations;
and provided further that such Key Employee or Director shall remain bound by the terms and conditions of the Plan. The person
or persons to whom an Award is transferred by will or by the laws of descent and distribution (or with the Committee’s consent)
thereafter shall be treated as the Key Employee or Director with respect to such Award.
Section
13.
SECURITIES
REGISTRATION
As a condition to the
receipt of shares of Stock under this Plan, the Key Employee or Director shall, if so requested by the Company, agree to hold such
shares of Stock for investment and not with a view toward resale or distribution to the public and, if so requested by Company,
shall deliver to Company a written statement satisfactory to Company to that effect. Furthermore, if so requested by the Company,
the Key Employee or Director shall make a written representation to Company that he or she will not sell or offer for sale any
of such Stock unless a registration statement shall be in effect with respect to such Stock under the 1933 Act and any applicable
federal or state securities law or he or she shall have furnished to Company an opinion in form and substance satisfactory to Company
or its legal counsel satisfactory to Company that such registration is not required. Certificates representing the Stock transferred
upon the exercise of an Option, Stock Appreciation Right or Restricted Stock Unit or upon the lapse of the forfeiture conditions,
if any, on any Stock Grant may at the discretion of Company bear a legend to the effect that such Stock has not been registered
under the 1933 Act or any applicable state securities law and that such Stock cannot be sold or offered for sale in the absence
of an effective registration statement as to such Stock under the 1933 Act and any applicable state securities law or an opinion
in form and substance satisfactory to the Company of legal counsel satisfactory to the Company that such registration is not required.
Section
14.
LIFE
OF PLAN
No Award shall be made
under this Plan on or after the earlier of (1) the tenth anniversary of the effective date of this Plan (as determined under §
4), in which event this Plan otherwise thereafter shall continue in effect until all outstanding Options and Stock Appreciation
Rights have been exercised in full or no longer are exercisable, all Stock issued under any Stock Grants under this Plan have been
forfeited or have become non-forfeitable, all Restricted Stock Units have vested and all Performance Periods have ended, or (2)
the date on which all of the Stock reserved under § 3 has (as a result of the exercise of Options or Stock Appreciation Rights
granted under this Plan the satisfaction of the forfeiture conditions, if any, on Stock Grants, or the payment of shares upon the
vesting of Restricted Stock Units) been issued or no longer is available for use under this Plan, in which event this Plan also
shall terminate on such date.
Section
15.
ADJUSTMENT
15.1 Capital
Structure. The number, kind or class (or any combination thereof) of shares of Stock reserved under § 3, the annual grant
caps described in § 6, the number, kind or class (or any combination thereof) of shares of Stock subject to Options, Restricted
Stock Units or Stock Appreciation Rights granted under this Plan, the Option Price of such Options, the SAR Value of such Stock
Appreciation Rights as well as the number, kind or class (or any combination thereof) of shares of Stock subject to Stock Grants
granted under this Plan shall be adjusted by the Committee in an equitable manner to reflect any change in the capitalization of
the Company, including, but not limited to, such changes as stock dividends or stock splits.
15.2 Mergers.
The Committee as part of any corporate transaction described in § 424(a) of the Code shall have the right to adjust (in any
manner which the Committee in its discretion deems consistent with § 424(a) of the Code) the number, kind or class (or any
combination thereof) of shares of Stock reserved under § 3 and the annual grant caps described in § 6. Furthermore, the
Committee as part of any corporate transaction described in § 424(a) of the Code shall have the right to adjust (in any manner
which the Committee in its discretion deems consistent with § 424(a) of the Code) the number, kind or class (or any combination
thereof) of shares of Stock subject to any outstanding Stock Grants under this Plan and any related grant conditions and forfeiture
conditions, and the number, kind or class (or any combination thereof) of shares subject to Option, Restricted Stock Unit and Stock
Appreciation Right grants previously made under this Plan and the related Option Price and SAR Value for each such Option Stock
Appreciation Right and, further, shall have the right (in any manner which the Committee in its discretion deems consistent with
§ 424(a) of the Code and without regard to the annual grant caps described in § 6 of this Plan) to make any Stock Grants
and Option Stock Appreciation Right and Restricted Stock Unit grants to effect the assumption of, or the substitution for, stock
grants and option, restricted stock unit and stock appreciation right grants previously made by any other corporation to the extent
that such corporate transaction calls for such substitution or assumption of such stock grants and stock option, restricted stock
unit and stock appreciation right grants.
15.3 Fractional
Shares. If any adjustment under this § 15 would create a fractional share of Stock or a right to acquire a fractional
share of Stock, such fractional share shall be disregarded and the number of shares of Stock reserved under this Plan and the number
subject to any Options, Restricted Stock Unit or Stock Appreciation Right grants and Stock Grants shall be the next lower number
of shares of Stock, rounding all fractions downward. An adjustment made under this § 15 by the Committee shall be conclusive
and binding on all affected persons.
Section
16.
CHANGE
IN CONTROL
16.1 Assumption
or Substitution of Certain Awards. Unless otherwise provided in an Award Agreement, in the event of a Change in Control in
which the successor company assumes or substitutes for an Option, Restricted Stock Unit, Stock Appreciation Right, or Stock Grant,
if a Key Employee’s employment with such successor company (or a subsidiary thereof) terminates under the circumstances specified
in the Award Agreement within 24 months following such Change in Control (or such other period set forth in the Award Agreement,
including prior thereto if applicable): (i) Options and Stock Appreciation Rights outstanding as of the date of such termination
of employment will immediately vest, become fully exercisable, and may thereafter be exercised for 24 months (or the period of
time set forth in the Award Agreement), and (ii) restrictions, limitations and other conditions applicable to Restricted Stock
Units and Stock Grants shall lapse and the Restricted Stock Units and Stock Grants shall become free of all restrictions and limitations
and become fully vested. For the purposes of this Section 11.2, an Option, Restricted Stock Unit, Stock Appreciation Right, Award
or Stock Grant shall be considered assumed or substituted for if following the Change in Control the Award confers the right to
purchase or receive, for each share of Stock subject to the Option, Restricted Stock Unit, Stock Appreciation Right, or Stock Grant
immediately prior to the Change in Control, the consideration (whether stock, cash or other securities or property) received in
the transaction constituting a Change in Control by holders of shares of Stock for each share of Stock held on the effective date
of such transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of
a majority of the outstanding shares); provided, however, that if such consideration received in the transaction constituting a
Change in Control is not solely common stock of the successor company, the Committee may, with the consent of the successor company,
provide that the consideration to be received upon the exercise or vesting of an Option, Restricted Stock Unit, Stock Appreciation
Right or Stock Grant, for each share of Stock subject thereto, will be solely common stock of the successor company substantially
equal in fair market value to the per share consideration received by holders of shares of Stock in the transaction constituting
a Change in Control. The determination of such substantial equality of value of consideration shall be made by the Committee in
its sole discretion and its determination shall be conclusive and binding.
16.2 Non-Assumption
or Substitution of Certain Awards. Unless otherwise provided in an Award Agreement in the event of a Change in Control, to
the extent the successor company does not assume or substitute for an Option, Restricted Stock Unit, Stock Appreciation Right,
or Stock Grant: (i) those Options and Stock Appreciation Rights outstanding as of the date of the Change in Control that are not
assumed or substituted for shall immediately vest and become fully exercisable, and (ii) restrictions and deferral limitations
on Restricted Stock Units and Stock Grants that are not assumed or substituted for shall lapse and the Restricted Stock Units and
Stock Grants shall become free of all restrictions and limitations and become fully vested.
16.3 Impact
on Certain Awards. Award Agreements may provide that in the event of a Change in Control: (i) Options and Stock Appreciation
Rights outstanding as of the date of the Change in Control shall be cancelled and terminated without payment therefor if the Fair
Market Value of one share of Stock as of the date of the Change in Control is less than the Option Price or SAR Value, and (ii)
all Performance Units shall be considered to be earned and payable (either in full or pro rata based on the portion of Performance
Period completed as of the date of the Change in Control), and any limitations or other restriction shall lapse and such Performance
Units shall be immediately settled or distributed.
16.4 Termination
of Certain Awards. The Committee, in its discretion, may determine that, upon the occurrence of a Change in Control, each Option
and Stock Appreciation Right outstanding shall terminate within a specified number of days after notice to the Key Employee or
Director, and/or that each Key Employee or Director shall receive, with respect to each share of Stock subject to such Option or
Stock Appreciation Right, an amount equal to the excess of the Fair Market Value of such share immediately prior to the occurrence
of such Change in Control over the Option Price of such Option and the SAR Value of such Stock Appreciation Right; such amount
to be payable in cash, in one or more kinds of stock or property (including the stock or property, if any, payable in the transaction)
or in a combination thereof, as the Committee, in its discretion, shall determine.
Section
17.
AMENDMENT
OR TERMINATION
This Plan may be amended
by the Board from time to time to the extent that the Board deems necessary or appropriate; provided, however, (1) no amendment
shall be made absent the approval of the stockholders of the Company to the extent such approval is required under applicable law
or exchange rule and (2) no amendment shall be made to § 16 on or after any date described in § 16 which might adversely
affect any rights which otherwise vest on such date. The Board also may suspend granting Awards under this Plan at any time and
may terminate this Plan at any time; provided, however, the Board shall not have the right unilaterally to modify, amend or cancel
any Award made before such suspension or termination unless (x) the Key Employee or Director consents in writing to such modification,
amendment or cancellation or (y) there is a dissolution or liquidation of the Company or a transaction described in § 15 or
§ 16.
Section
18.
MISCELLANEOUS
18.1 Stockholder
Rights. No Key Employee or Director shall have any rights as a stockholder of the Company as a result of the grant of an Option
or a Restricted Stock Unit or Stock Appreciation Right pending the actual delivery of the Stock subject to such Option, Restricted
Stock Unit or Stock Appreciation Right to such Key Employee or Director. Subject to § 10.3, a Key Employee’s or Director’s
rights as a stockholder in the shares of Stock underlying a Stock Grant which is effective shall be set forth in the related Stock
Grant Certificate.
18.2 No
Contract of Employment or Service. The grant of an Award to a Key Employee or Director under this Plan shall not constitute
a contract of employment or service and shall not confer on a Key Employee or Director any rights upon his or her termination of
employment or service in addition to those rights, if any, expressly set forth in the related Option Certificate, Restricted Stock
Unit Certificate, Stock Appreciation Right Certificate, Stock Grant Certificate, or Performance Unit agreement.
18.3 Withholding.
Each Option, Stock Appreciation Right, Restricted Stock Unit, Performance Unit and Stock Grant, shall be made subject to the condition
that the Key Employee consents to whatever action the Committee directs to satisfy the statutory federal and state tax withholding
requirements, if any, which the Company determines are applicable to the exercise of such Option or Stock Appreciation Right, the
payment of shares upon the vesting of such Restricted Stock Unit, the satisfaction of any forfeiture conditions with respect to
Stock subject to a Stock Grant issued in the name of the Key Employee, or to the payment for the Performance Units. The Committee
also shall have the right to provide in an Award agreement that a Key Employee may elect to satisfy such statutory federal and
state tax withholding requirements through a reduction in the cash or the number of shares of Stock actually transferred to him
or to her under this Plan. No withholding through a reduction in shares of Stock shall be effected under this Plan which exceeds
the minimum statutory federal and state withholding requirements, unless it will not trigger a negative accounting impact.
18.4 Construction.
All references to sections (§) are to sections (§) of this Plan unless otherwise indicated. This Plan shall be construed
under the laws of the State of Delaware. Finally, each term set forth in § 2 shall have the meaning set forth opposite such
term for purposes of this Plan and, for purposes of such definitions, the singular shall include the plural and the plural shall
include the singular.
18.5 Other
Conditions. Each Award may require that a Key Employee or Director (as a condition to the exercise of an Option or a Stock
Appreciation Right, the payment of shares upon the vesting of a Restricted Stock Unit or the issuance of Stock subject to a Stock
Grant) enter into any agreement or make such representations prepared by the Company, including (without limitation) any agreement
which restricts the transfer of Stock acquired pursuant to the exercise of an Award or provides for the repurchase of such Stock
by the Company.
18.6 Rule
16b-3. The Committee shall have the right to amend any Award to withhold or otherwise restrict the transfer of any Stock or
cash under this Plan to a Key Employee or Director as the Committee deems appropriate in order to satisfy any condition or requirement
under Rule 16b-3 to the extent Rule 16 of the 1934 Act might be applicable to such grant or transfer.
IN WITNESS WHEREOF,
BioScrip, Inc. has caused its duly authorized officer to execute this Plan to evidence its adoption of this Plan.
BIOSCRIP, INC. |
|
|
|
|
By: |
/s/ Kimberlee C. Seah |
|
|
|
|
Date: |
May 8, 2014 |
|
EXHIBIT 99.1
![](image_001.jpg)
PRESS RELEASE
Contact:
Hai Tran, Chief Financial
Officer
BioScrip
952-979-3768
BIOSCRIP STOCKHOLDERS
ELECT New Independent Director
Yon
Y. Jorden to board of directors
ELMSFORD, N.Y., May 14, 2014 – BioScrip, Inc. (NASDAQ:
BIOS) today announced that at BioScrip’s 2014 Annual Meeting held on May 8, 2014, its stockholders voted to elect new independent
director Yon Y. Jorden, expanding the size of the Board of Directors from nine to ten members, nine of whom are independent and
all of whom are elected annually.
Ms. Jorden has more than a decade of leadership experience in
health care services and has served as Chief Financial Officer for several publicly-traded health care companies over her career,
including AdvancePCS, Oxford Health Plans, Inc. and Wellpoint, Inc. She also has additional expertise across the technology and
manufacturing industries. Throughout her career, Ms. Jorden has focused on complex financial transactions, including initial public
offerings and mergers and acquisitions, which will bring additional valuable perspective to the BioScrip Board. Ms. Jorden will
serve on BioScrip’s Audit Committee and Management Development and Compensation Committee.
“Yon’s extensive public company Board experience,
strong financial background and deep knowledge of healthcare will add considerable value to BioScrip’s execution of its ongoing
strategic priorities,” said Rick Smith, President and Chief Executive Officer of BioScrip. “We believe BioScrip is
a dynamic company with strong growth potential in the infusion industry. Since the beginning of the year, we have welcomed two
highly qualified independent directors to our Board, and we look forward to building on our recent success as we benefit from Yon’s
perspective and expertise.”
Ms. Jorden is a National Association of Corporate Directors
(NACD) Board Leadership Fellow and currently serves on the board of directors of Methodist Health System, a Texas-based not-for-profit
hospital system, and Maxwell Technologies, Inc., a publicly-traded manufacturer of energy storage and power delivery solutions.
She previously served on the board of directors of Magnetek, Inc. and U.S. Oncology.
Caldwell Partners assisted BioScrip’s Board with its director
search process.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion and
home care solutions. BioScrip partners with physicians, hospital systems, healthcare payors, and pharmaceutical manufacturers to
provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and
related healthcare infusion therapy services into the home or alternate- site setting. By collaborating with the full spectrum
of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by quality, customer service,
and values that promote positive outcomes and an enhanced quality of life for those it serves. BioScrip provides its infusion and
home care services from over 80 locations across 29 states.
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024